Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John C. Byrd, MD
Ohio State University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
387 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Moncton Hospital
Moncton, New Brunswick, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Northeastern Ontario Regional Cancer Centre
Greater Sudbury, Ontario, Canada
- Margaret and Charles Juravinski Cancer Centre
Hamilton, Ontario, Canada
- Edmond Odette Cancer Centre at Sunnybrook
Toronto, Ontario, Canada
- Maisonneuve-Rosemont Hospital
Montreal, Quebec, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
- Regional Medical Center
Anniston, Alabama, United States
- Clearview Cancer Institute
Huntsville, Alabama, United States
- Sparks Regional Medical Center
Fort Smith, Arkansas, United States
- Providence Saint Joseph Medical Center - Burbank
Burbank, California, United States
- Virginia K. Crosson Cancer Center at St. Jude Medical Center
Fullerton, California, United States
- Memorial Medical Center
Modesto, California, United States
- Camino Medical Group - Treatment Center
Mountain View, California, United States
- Palo Alto Medical Foundation
Palo Alto, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- Kaiser Permanente Medical Office -Vandever Medical Office
San Diego, California, United States
- Aurora Presbyterian Hospital
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
- Ccop - Colorado Cancer Research Program
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - St. Luke'S Medical Center
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- St. Anthony Central Hospital
Denver, Colorado, United States
- St. Joseph Hospital
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- St. Mary'S Regional Cancer Center at St. Mary'S Hospital and Medical Center
Grand Junction, Colorado, United States
- North Colorado Medical Center
Greeley, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado, United States
- Mckee Medical Center
Loveland, Colorado, United States
- St. Mary - Corwin Regional Medical Center
Pueblo, Colorado, United States
- North Suburban Medical Center
Thornton, Colorado, United States
- Exempla Lutheran Medical Center
Wheat Ridge, Colorado, United States
- Manchester Memorial Hospital
Manchester, Connecticut, United States
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Washington D.C., District of Columbia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2008
- Primary completion
- 30 Jun 2016
- Completion
- 30 Jun 2016
- Last update posted
- 22 Apr 2020
- Registered enrollment
- 84
- Registry id
- NCT00513747
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.